Publication: Proteomic screening for novel therapeutic targets in kidney diseases
Issued Date
2006-03-01
Resource Type
ISSN
15672042
Other identifier(s)
2-s2.0-39849084928
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Frontiers in Drug Design and Discovery. Vol.2, No.1 (2006), 87-102
Suggested Citation
Visith Thongboonkerd Proteomic screening for novel therapeutic targets in kidney diseases. Frontiers in Drug Design and Discovery. Vol.2, No.1 (2006), 87-102. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/23067
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Proteomic screening for novel therapeutic targets in kidney diseases
Author(s)
Other Contributor(s)
Abstract
The high-throughput capability of proteomics allows simultaneous examination of numerous proteins and makes a global analysis of proteins in cell, tissue, organ or biofluid possible. This strength of proteomics has been extensively applied to examine altered proteins caused by various diseases. Some of these altered proteins may particularly be important for the disease progression and/or complications. Thus, information on these altered proteins is valuable for better understanding of the pathogenesis and pathophysiology of medical diseases. Additionally, functional analysis of such proteins may lead to identification of novel therapeutic targets and development of new drugs for improving therapeutic outcome as well as for preventing serious complications. This review focuses mainly on applications of renal and urinary proteomics to define novel therapeutic targets in kidney diseases. Several recent studies on various kidney diseases have successfully identified altered renal and urinary proteins, some of which may potentially be the novel therapeutic targets. Urinary proteome profiling has also been applied to biomarker discovery that will be useful for clinical diagnostics, prognosis, prediction of treatment response, and development of personalized medicine. Finally, potential roles of proteomics for drug design and discovery are discussed. All rights reserved - © 2006 Bentham Science Publishers.